Natera, Inc. has grown revenue 43% a year over three years and 40% a year over five. Revenue growth, 3-year annual rate: +43% (Diagnostics & Research median +8.4%). Revenue growth, 5-year rate: +40%, growth has picked up over the last three years. Years of annual history on file: 13, FY2013 to FY2025, as filed.

NTRANatera, Inc.

Healthcare

$400.63+121% 1Y

$400.63

$160.2152 weeks$425.55

Is it growing?

Good

Growing: revenue growing +38% year on year and operating margin widening (+3.8 points).

2 good, 1 without data

Revenue trend+38% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +40% a year.

Margin direction+3.8 points operating

Trailing-twelve-month operating margin, -10.8% now against -14.6% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

Revenue growth, 3 yearstop 2% of the market

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is NTRA growing?

Natera, Inc. has grown revenue 43% a year over three years and 40% a year over five.

+43%

Revenue growth, 3-year annual rate · Diagnostics & Research median +8.4% · compounding fast · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +40%
Revenue growth, 5-year rate · +43% over three · growth has picked up over the last three years
Years of annual history on file: 13
Years of annual history on file · FY2013 to FY2025, as filed

Details›